Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  laromustine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-14 of 14 for your search:
Start Over
Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic (MD) Syndrome With Laromustine and Infusional Cytarabine
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 60 and over
Sponsor: Other
Protocol IDs: 0702009008, VNP40101M, NCT00655395
Laromustine, Daunorubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: Other
Protocol IDs: CDR0000634230, IPC-LAM-HR, IPC-2006-007, INCA-RECF0902, EUDRACT-2007-001082-15, LAM-HR, NCT00840684
Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: 2005-0844, NCT00521859
VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors
Phase: Phase I
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI, Other
Protocol IDs: CDR0000396779, PBTC-017, VION-VNP40101M, NCT00098761
Start Over